Overview of Dr. Movva
Dr. Sujana Movva is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from University of Western Ontario and has been in practice 17 years. She is one of 464 doctors at Memorial Sloan Kettering Cancer Center and one of 88 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. She has 3 publications and 2 citings.
Office
Memorial Sloan Kettering Cancer Center New York
1275 York Avenue
New York, NY 10021- Is this information wrong?
Education & Training
University of Western OntarioClass of 2003
University of New Mexico School of MedicineFellowship, Hematology and Medical Oncology
McLaren Health Care/Flint/MSUResidency, Internal Medicine
Certifications & Licensure
FL State Medical License 2021 - Present
NJ State Medical License 2018 - 2025
NY State Medical License 2018 - 2024
CT State Medical License 2023 - 2024
NC State Medical License 2020 - 2022
PA State Medical License 2012 - 2018
GA State Medical License 2010 - 2013- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Lurbinectedin + Doxorubicin In Leiomyosarcoma Start of enrollment: 2022 Feb 04
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma.Josephine K Dermawan, Sarah Chiang, Samuel Singer, Bhumika Jadeja, Martee L Hensley, William D Tap, Sujana Movva, Robert G Maki, Cristina R Antonescu> ;Clinical Cancer Research. 2024 Mar 15
- Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma.Gleason, C., Dickson, M., Klein Dooley, M., Antonescu, C., Gularte-Mérida, R., Benitez, M., Delgado, J., Kataru, R., Tan, M., Bradic, M., Adamson, T., Seier, K., Richa...> ;Clinical Cancer Research. 2024 Feb 16
- 2 citationsImmune-related Adverse Events after Immune Checkpoint Blockade-based Therapy Are Associated with Improved Survival in Advanced Sarcomas.Evan Rosenbaum, Kenneth Seier, Martina Bradic, Ciara Kelly, Sujana Movva, Benjamin A Nacev, Mrinal M Gounder, Mary L Keohan, Viswatej Avutu, Ping Chi, Katherine A Thor...> ;Cancer Research Communications. 2023 Oct 18
Hospital Affiliations
Memorial Sloan Kettering Cancer CenterNew York, New York- Memorial Hospital for Cancer and allied DiseasesBasking Ridge, New Jersey
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
